A 39-year-old unvaccinated Franklin County woman has died after a recent measles diagnosis. Nationally, numbers continue to increase and the US has passed 4,000 cases.
|Articles|March 24, 2020
FDA Issues Alert on Potential Risk of SARS-CoV-2 Transmission Through FMT
Author(s)Contagion® Editorial Staff
The FDA has issued a safety alert on the potential risk of transmitting SARS-CoV-2, the virus that causes coronavirus diseases 2019 (COVID-19), through fecal microbiota transplantation.
Advertisement
The US Food and Drug Administration (FDA) has
In the alert, published today, the FDA indicates that additional safety measures are needed after multiple studies reported that SARS-CoV-2 ribonucleic acid and/or SARS-CoV-2 virus was present in the stool of infected individuals.
Based on these studies, the virus may potentially be transmitted through fecal microbiota transplantation; however, the risk of transmission is unknown at this time.
Disruptions to health care activities due to the ongoing pandemic may result in decreased accessibility to nasopharyngeal specimen testing from stool donors. Additionally, little is known about the sensitivity and availability of direct testing of stool for SARS-CoV-2.
The FDA’s current recommendations for FMT include:
- Screening for donors should include questions that identify individuals who may currently be or recently were infected with SARS-CoV-2.
- Donors and/or donor stool should be tested for SARS-CoV-2, as feasible.
- Criteria should be developed for the exclusion of donors and donor stool based on screening and testing.
- Informed consent should include information about potential transmission of SARS-CoV-2 through fecal microbiota transplantation, including stool from donors who are asymptomatic for COVID-19.
The FDA indicates that more guidance will be provided as more information about this situation becomes available.
Advertisement
Related to this article
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
With US measles cases nearing 3,900 this year and Pennsylvania reporting its fifth measles-related death, here is a review of how the virus spreads, how it is prevented and managed, and what severe disease looks like.
Vaxcyte's 31-valent pneumococcal conjugate vaccine candidate met every prespecified primary immunogenicity and safety endpoint against PCV20 and PCV21 in the OPUS-1 trial of 4,047 US adults.
Irkutsk anti-plague institute death prompts quarantines and conflicting official accounts.
A laboratory technician at a Siberian anti-plague institute has died of pneumonia of unknown cause, prompting quarantines and contact monitoring while Russian officials stop short of confirming plague.
A study finding clesrovimab comparable to palivizumab in protecting at-risk infants in their first RSV season was extended to demonstrate clesrovimab effective and well-tolerated when administered in their second season.
Advertisement
Advertisement